Agenda

Conference Program

25 April 2018

Intellectual Property Rights in Pharmaceutical Industry 

Chamber of Commerce and Industry of the Russian Federation, Congress Centre  

Bldg. 1, 6/1, Ilyinka st., Moscow

9:00–9:45         Registration. Welcome coffee      
9:45–10:00

Welcome address: Tatiana Monaghan, Secretary General, ICC Russia

Protection of intellectual property as a key factor in the development of innovations in the pharmaceutical industry

Vadim Kukava, Executive Director, The Association of Pharmaceutical Companies «Innovative Pharma»

10:00–11:30 Session I. Trademarks: case law and regulatory issues

Moderator: Andrey Moskvitch, Director, IP, BIOCAD

Topics for discussion:

  • Practice of the Intellectual Property Court of Russia

Maria Kolzdorf, Deputy Head of the Department of Judicial Practice and Statistics, Intellectual Property Court

  • Disputes on trademarks in the field of pharmaceuticals*

Maria Ostashenko, Partner and Head of Intellectual Property Practice, ALRUD

  • Parallel import of medicines: where are we going?

Helen Avakyan, counsel “Egorov, Puginsky, Afanasiev & Partners”

  • Intellectual Property Issues Facting American Drug Developers in the Russian Federation: Comparison and Contrast with U.S. and International Practice

Bruce McDonald, partner Smith, Gambrell & Russell, Washington

11:30–12:00 Coffee break
12:00–14:00 Session II.  Patents: registration and rights protection
 
Moderator: Eugene Arievich, 
Chairman of the ICC Russia Commission on Intellectual Property; partner, Baker McKenzie

Topics for discussion:

  • Methodology for consideration of applications for patents relating to medicines

Lyubov Kiriy, Federal Intellectual Property, Patent and Trademark Service

  • Features of registration of the reproduced medicinal products in the presence of a valid patent / Legislative Initiatives / Interaction with the FAS on the legality of participation in public tenders in the context of violations of patent rights

Irina Sheikha, Legal and Communications Director of the Association of International Pharmaceuticals Manufacturers*

  • Case study: experience in protecting against the actions of manufacturers of generic drugs
Alexey Belozersky, Director of the Legal Department Novartis-Oncology 
Natalia Gulyaeva,  Partner and Head of Intellectual Property and Health Practice, Hogan Lovells

  • Patent linkage: foreign experience and possibilities of use in Russia
Darya Ermolina, counsel Baker McKenzie 

  • International experience in medicines patenting. "Bolar exemption"
Peter Thomsen, Sen. Patent Counsel IP Policy & Litigation, Novartis International AG, Basel

  • Effective ways to protect rights in case of patent infringement: what is the Russian Civil Coge silent about and is there a place fot creativity?
Nikolay Voznesenskiy, Partner Bryan Cave Leighton Paisner (Russia) LLP
Evgeny Oreshin, Head of Group Bryan Cave Leighton Paisner (Russia) LLP

  • Originators and  generics: are the interests really different? Fair launch practices
Alexander Korolenko, IP Executive for Russia and Eurasia, Teva Pharmaceuticals
14:00–15:00 Lunch break
15:00-16:30 Session III.   What do you know about medicines advertising?
 
Moderator: Ivan Pavlovich, General Counsel, Teva

Topics for discussion:

  • The main trends of FAS Russia's practice on medicines advertising?
Representative of the Federal Antimonopoly Service of the Russian Federation*

  • Medicines advertising: guarantee of effectiveness, inaccurate information, communication about properties beyond the limits of indications in instructions
Irina Shurmina, associate, Bryan Cave Leighton Paisner (Russia)

  • How to reconcile the advertising of medicines fot TV?
Daria Volkova
Head of Advertising Department, Legal Affairs Department, Media Business Solutions


  • Medical Advertising. Ethical Aspects
Dmitry Grigoriev, 
Head of Legal EMG
16:30 Closing remarks
* - to be determined